NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 24, 2024 Bullish $52.12 X 0
May 22, 2024 $65.48 +1.95% $63.01 X 96.08% 0
May 22, 2024 Bullish $63.01 X 0
Apr 30, 2024 $73.50 -2.55% $79.58 X 92.36% 0
Apr 30, 2024 $74.22 -1.59% $79.58 X 93.26% 0
Apr 30, 2024 Bearish $79.58 X 0
Apr 5, 2024 $75.47 +2.43% $76.45 V 98.72% 2
thedean2010 thedean2010 Merchant
Apr 5, 2024 Bullish $76.45 V 1
Apr 3, 2024 $75.50 -2.39% $78.44 X 96.25% 0
ngbots ngbots Merchant
Apr 3, 2024 $80.00 +3.43% $78.44 V 98.01% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE